Researchers find new clues to controlling HIV

Researchers Find New Clues To Controlling HIV essay is one based on this Health and Medical Updates groups, written much as our publisher Linda Norton on top of February 1, 2019, this paragraph might want to search much as these tags clues, Controlling, find, HIV, Researchers. We're joyful to blissful you together with providing those anothers article in regard health moreover we always posting those blogpost frequenlty.

Sfuresearche.jpg

Simon Fraser University professor Mark Brockman (l) is part of an international research team that is investigating a connection between infection control and how well antiviral T cells respond to diverse HIV sequences. Credit: SFU

The immune system is the body’s best defense in fighting diseases like HIV and cancer. Now, an international team of researchers is harnessing the immune system to reveal new clues that may help in efforts to produce an HIV vaccine.

SFU professor Mark Brockman and co-authors from the University of KwaZulu-Natal in South Africa have identified a connection between infection control and how well antiviral T cells respond to diverse HIV sequences.

Brockman explains that HIV adapts to the human immune system by altering its sequence to evade helpful antiviral T cells.

“So to develop an effective HIV vaccine, we need to generate host immune responses that the virus cannot easily evade,” he says.

Brockman’s team has developed new laboratory-based methods for identifying antiviral T cells and assessing their ability to recognize diverse HIV sequences.

“T cells are white blood cells that can recognize foreign particles called peptide antigens,” says Brockman. “There are two major types of T cells—those that ‘help’ other cells of the immune system, and those that kill infected cells and tumours.”

Identifying the T cells that attack HIV antigens sounds simple, but Brockman says three biological factors are critical to a T cell-mediated immune response. And in HIV infection, all three are highly genetically diverse.

He explains that for a T cell to recognize a peptide antigen, the antigen must first be presented on the cell surface by human leukocyte antigen proteins (HLA), which are are inherited.

And since many thousands of possible HLA variants exist in the human population, every person responds differently to infection. In addition, since HIV is highly diverse and evolves constantly during untreated infection, the peptide antigen sequence also changes.

Matching T cells against the HLA variants and HIV peptide antigens expressed in an individual is a critical step in the routine research process. But, says Brockman, “our understanding of T cell responses will be incomplete until we know more about the antiviral activity of individual T cells that contribute to this response.”

It is estimated that a person’s T cell “repertoire” is made up of a possible 20-100 million unique lineages of cells that can be distinguished by their T cell receptors (TCR), of which only a few will be important in responding to a specific antigen.

So to reduce the study’s complexity, the team examined two highly related HLA variants (B81 and B42) that recognize the same HIV peptide antigen (TL9) but are associated with different clinical outcomes following infection.

By looking at how well individual T cells recognized TL9 and diverse TL9 sequence variants that occur in circulating HIV strains, the researchers found that T cells from people who expressed HLA B81 recognized more TL9 variants compared to T cells from people who expressed HLA B42.

Notably, a group of T cells in some B42-expressing individuals displayed a greater ability to recognize TL9 sequence variants. The presence of these T cells was associated with better control of HIV infection.

This study demonstrates that individual T cells differ widely in their ability to recognize peptide variants and suggests that these differences may be clinically significant in the context of a diverse or rapidly evolving pathogen such as HIV.

Much work needs to be done to create an effective vaccine. However, says Brockman, “Comprehensive methods to assess the ability of T cells to recognize diverse HIV sequences, such as those reported in this study, provide critical information to help design and test new vaccine strategies.”


Machine learning tool predicts the potential of peptides as immune activators


More information:
Funsho Ogunshola et al, Dual HLA B*42 and B*81-reactive T cell receptors recognize more diverse HIV-1 Gag escape variants, Nature Communications (2018). DOI: 10.1038/s41467-018-07209-7


Provided by
Simon…

You maybe want to discover others essay health with our related post or you probably want to check it by favoured essay, I am always publishing that health post frequenlty for information plus clue as well as trick in order to keep it save our health as well living these healthy lifestyle. That post is posted at Linda Norton with the title Researchers Find New Clues To Controlling HIV.

Related posts of "Researchers find new clues to controlling HIV"

New role for death molecule

Shown here, cross section of gut of normal mice. Researchers examined the gut of mice lacking TRADD and RIP and saw severe inflammation from dying cells. Credit: John Dowling, Jefferson (Philadelphia University + Thomas Jefferson University). Cellular death is vital for health. Without it, we could develop autoimmune diseases or cancers. But a cell's decision...

Researchers characterize mechanism of action of CAR T cells

Scanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAID The scientific community has made great strides over the past decade in the development of a new class of cancer therapy called immunotherapy, a treatment that activates a patient's own immune system...

Bioluminescent deep-sea creatures illuminate the effectiveness of new cancer therapies

Preet. M Chaudhary, MD, PhD, Keck School of Medicine of USC. Credit: Ricardo Carrasco III Researchers at the Keck School of Medicine of USC have developed a new laboratory tool, which is poised to improve the development and effectiveness of a burgeoning group of therapies that use patients' immune systems to fight cancer with genetically...

The BMJ launches campaign for adequate rest breaks for doctors

Credit: CC0 Public Domain Today, The BMJ launches the 'give us a break' campaign calling for doctors to be able to take the breaks that they need—for their own wellbeing and for patient safety. For many doctors working in the NHS or any other over-stretched health system, working long and often unsociable hours without adequate...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.